MEDICINES CONTROL COUNCIL

Similar documents
MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

Medicines availability short-term supply issues Last updated 01/05/18

Kern Pharma Portfolio 2014

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013

TLS HEALTH Product list up-dated 2017 (Origin: Portugal)

Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001

BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

BabyJabs Vaccines. All vaccines are mercury-free We use aluminium-free vaccines wherever possible

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

NIT 97 - APPROVED DRUG LIST

ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Product List Finished Dosage Forms (FDF) B2B Business

Acetaminophen 500 mg Diphenhydramine HCl 25 mg. Pain Reliever, Nighttime Sleep Aid. counts: 24 Compare to Tylenol Simply Sleep. Naproxen Sodium 220 mg

TRIPACEL Pertussis Vaccine-Acellular, Combined with Diphtheria and Tetanus Toxoids (Adsorbed)

UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:

Rajasthan Medical Services Corporation Limited, Jaipur

PRODUCT LIST GENERAL - TABLETS

Alaska Medicaid 90 Day** Generic Prescription Medication List

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003

ADACEL POLIO. This leaflet answers some common questions about ADACEL POLIO. It does not take the place of talking to your doctor or pharmacist.

BabyJabs Vaccines. All vaccines are mercury- free We use aluminium- free vaccines wherever possible

EUROPEAN MEDICINES AGENCY DECISION. of 31 March 2009

Use of Infanrix -IPV+Hib in the infant primary immunisation schedule

As a result of these reviews, Discovery Health has updated its Chronic Medicine Formulary and CDA.

New Exception Status Benefits

Development of Recombinant Pertussis Vaccines

ADCO-CAPTOPRIL 25MG BIO-CAPTOPRIL 25MG MERCK-CAPTOPRIL 25MG SANDOZ CAPTOPRIL 25MG ZAPTO 25MG TAB

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014

DT Description Price Category Price change

Information for Vermont Prescribers of Prescription Drugs

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS

DATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS:

Information for Vermont Prescribers of Prescription Drugs

Pharmacy Savings Program

Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS

Packing List SS#: From: HEALTH PARTNERS INTERNATIONAL 2907 PORTLAND DRIVE OAKVILLE ON CANADA L6H 5S4. Ship to: Carrier:

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

DAPTACEL National Drug Code Directory

Tablets, Capsules, Syrup, Dry syrup, Suspensions, Lotions and food products.

List of changes in Out-Patients Formulary

CONTACT POLPHARMA GROUP POLPHARMA B2B

Immunisation Subcommittee of PTAC Meeting held 28 October 2015

AUSTRALIAN PRODUCT INFORMATION


Care at the Chemist. Formulary

MRP Monthly Update MRP 12/2013

Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV)

Care at the Chemist. Formulary

Product List Rusan Pharma Ltd.

What s New

Information for Vermont Prescribers of Prescription Drugs

CONTRACT UPDATE July 20, 2012

TEPZZ A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 9/20 (2006.

Diphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib)

CONTRACT UPDATE June 15, 2012

Approved USP Compounded Monographs

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

Pharmaceuticals and Medical Devices. Safety Information

Anti Infectives. Product Generic Name Dosage Form Strength Available Pack Sizes. Powder for Oral Suspension

PHARMA LIMITED (NIGERIA)

Pharmaceuticals and Medical Devices Safety Information

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)

DATA SHEET. 1. PRODUCT NAME (strength pharmaceutical form)

PEDIACEL. Intramuscular injection. Suspension for injection. DESCRIPTION

List of Products Approved By Drugs Control Organization, Jaipur Sr. No. Name of Product Tablets Biological

Product Selection Committee / Comité de sélection des produits

Transcription:

Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/1.3/04 MC PHARMA (PTY) THIANIL/TREXONIL COMBIPACK Each pack contains: THIANIL VIAL containing: THIAFENTANIL OXALATE 10,0 mg/1,0 ml TREXONIL VIAL containing: NALTREXONE HYDROCHLORIDE /1,0 ml 06/1.3/05 MC PHARMA (PTY) TREXONIL Each vial contains: NALTREXONE HYDROCHLORIDE /1,0 ml 06/1.3/06 MC PHARMA (PTY) THIANIL Each vial contains: THIAFENTANIL OXALATE 10,0 mg/1,0 ml 34/21.5.1/0343 SCHERING-PLOUGH (PTY) 34/21.5.1/0344 SCHERING-PLOUGH (PTY) 37/5.8/0139 JOHNSON & JOHNSON (PTY) ASMANEX TWISTHALER 200 µg ASMANEX TWISTHALER 400 µg SINUTAB SINUS PAIN EXTRA STRENGTH Each inhalation delivers: MOMETASONE FUROATE 200,0 µg Each inhalation delivers: MOMETASONE FUROATE 400,0 µg PARACETAMOL 500,0 mg PSEUDOEPHEDRINE HYDROCHLORIDE 30,0 mg CHLORPHENIRAMINE MALEATE 2,0 mg CODEINE PHOSPHATE 10,0 mg 38/11.5/0166 PHARMACARE AGAROL LACTULOSE Each 5,0 ml syrup contains: LACTULOSE 3,3 mg 38/2.7/0261 WYETH S.A. (PTY) ADVIL LIQUI-GEL 400 IBUPROFEN 400,0 mg 12.48 Notification of Aug09v1.doc September 2009 Page 1 of 5

Notification of of Medicines A39/3.2/0352 A39/30.3/0591 A39/30.3/0592 A39/30.3/0593 A39/34/0647 A40/5.10/0323 A40/5.10/0324 A40/5.10/0325 A40/2.6.5/0527 A40/2.6.5/0528 A40/2.6.5/0529 A40/26/0609 A40/26/0610 A40/26/0611 PHARMACO DISTRIBUTION (PTY) ASTELLAS PHARMA (PTY) SUPLASYN 250 I.U. 500 I.U. 1 000 I.U. PROGRAF 0,5 mg SABAX COVAN PROPAN RESKIT 0,5 RESKIT 1 RESKIT 2 PCH-PACLITAXEL 30 PCH-PACLITAXEL 100 PCH-PACLITAXEL 300 A40/2.6.5/0674 SANDOZ SA (PTY) SANDOZ RISPERIDONE 1 A40/2.6.5/0675 SANDOZ SA (PTY) SANDOZ RISPERIDONE 2 A40/2.6.5/0676 SANDOZ SA (PTY) SANDOZ RISPERIDONE 3 A40/2.6.5/0677 SANDOZ SA (PTY) SANDOZ RISPERIDONE 4 A40/2.5/0768 A40/2.5/0769 A40/2.5/0770 S.A. (PTY) S.A. (PTY) S.A. (PTY) 50 mg TABLETS 100 mg TABLETS 200 mg TABLETS Each pre-filled syringe contains: SODIUM HYALURONATE 20,0 mg 250,0 I.U. 500,0 I.U. 1 000,0 I.U. TACROLIMUS 0,5 mg 4,0 mg 4,0 mg 4,0 mg RISPERIDONE 0,5 mg RISPERIDONE 1,0 mg RISPERIDONE 2,0 mg RISPERIDONE 1,0 mg RISPERIDONE 2,0 mg RISPERIDONE 3,0 mg RISPERIDONE 4,0 mg LAMOTRIGINE LAMOTRIGINE LAMOTRIGINE 200,0 mg 12.48 Notification of Aug09v1.doc September 2009 Page 2 of 5

Notification of of Medicines 41/7.1.3/0041 S.A. (PTY) 41/5.7.1/0119 GULF DRUG COMPANY (PTY) 41/26/0160 CIPLA LIFE SCIENCES (PTY) 41/26/0161 CIPLA LIFE SCIENCES (PTY) ZYDUS LISINOPRIL/HYDRO- CHLOROTHIAZIDE 20/12,5 mg LORMEG 10 CIPLA-CISPLATIN 10 CIPLA-CISPLATIN 50 LISINOPRIL DIHYDRATE LISINOPRIL 20,0 mg HYDROCHLOROTHIAZIDE 12,5 mg LORATADINE 10,0 mg Each 20,0 ml vial contains: CISPLATIN 10,0 mg Each 50,0 ml vial contains: CISPLATIN 41/21.5.1/0243 PHARMACARE REDIPRED Each 5,0 ml liquid contains: PREDNISOLONE SODIUM PHOSPHATE PREDNISOLONE 15,0 mg 41/7.1.3/0499 AUSTELL 41/7.1.3/0500 AUSTELL 41/7.1.3/0501 AUSTELL 41/7.1.3/0502 AUSTELL 41/7.1.3/0503 AUSTELL 41/7.1.3/0517 AUSTELL 41/7.1.5/0644 ELI LILLY (S.A.) (PTY) 41/7.1.5/0645 ELI LILLY (S.A.) (PTY) 41/7.1/0659 ACCORD HEALTHCARE (PTY) 41/7.1/0660 ACCORD HEALTHCARE (PTY) 41/20.2.8/0808 AUROBINDO PHARMA (PTY) 41/20.2.8/0809 AUROBINDO PHARMA (PTY) AUSTOZAAR 25 AUSTOZAAR 50 AUSTOZAAR 100 LORTELL-25 LORTELL-50 LORTELL-100 CIALIS 5 CIALIS 2,5 AMTAS 5 AMTAS 10 AURO-STAVUDINE 15 mg AURO-STAVUDINE 20 mg TADALAFIL 5,0 mg TADALAFIL 2,5 mg AMLODIPINE BESYLATE AMLODIPINE 5,0 mg AMLODIPINE BESYLATE AMLODIPINE 10,0 mg STAVUDINE 15,0 mg STAVUDINE 20,0 mg 41/30.2/0883 MERCK (PTY) ERBITUX 5 mg/ml CETUXIMAB 5,0 mg 12.48 Notification of Aug09v1.doc September 2009 Page 3 of 5

Notification of of Medicines 41/26/1002 ACCORD HEALTHCARE (PTY) 41/20.1.1/1018 AUSTELL 41/20.1.1/1019 AUSTELL ACCORD VINCRISTINE 1 mg/ml INJECTION AUSTELL 250 mg AUSTELL 500 mg VINCRISTINE SULPHATE 1,0 mg HEMIHYDRATE 2 HEMIHYDRATE 500,0 mg 41/7.1.3/1074 SPECPHARM (PTY) SPEC LOSARTAN 25 : 41/7.1.3/1075 SPECPHARM (PTY) SPEC LOSARTAN 100 41/7.1.3/1076 SPECPHARM (PTY) SPEC LOSARTAN 50 41/7.1.3/1077 SPECPHARM (PTY) SPEC LOSARTAN 12,5 12,5 mg 41/26/1095 SANDOZ SA (PTY) LOXAT 30 Each vial contains: PACLITAXEL 30,0 mg 41/26/1096 SANDOZ SA (PTY) LOXAT 100 Each vial contains: PACLITAXEL 41/26/1097 SANDOZ SA (PTY) LOXAT 300 Each vial contains:: PACLITAXEL 300,0 mg 41/2.9/1103 MEDWICH PHARMA (PTY) 41/2.9/1104 MEDWICH PHARMA (PTY) 41/2.9/1105 MEDWICH PHARMA (PTY) 42/30.1/0118 SANOFI-AVENTIS SOUTH AFRICA (PTY) OXYNORM 5 mg OXYNORM 10 mg OXYNORM 20 mg ADACEL QUADRA HYDROCHLORIDE 5,0 mg HYDROCHLORIDE 10,0 mg HYDROCHLORIDE 20,0 mg Each 0,5 dose contains: DIPHTHERIA TOXOID 2,0 Lf PERTUSSIS TOXOID 2,5 µg FILAMENTOUS HAEMAGGLUTININ 5,0 µg FIMBRIAE TYPE 2+3 5,0 µg PERTACTIN 3,0 µg TETANUS TOXOID 5,0 Lf TYPE 1 40 D-antigen units TYPE 2 8 D-antigen units TYPE 3 32 D-antigen units 12.48 Notification of Aug09v1.doc September 2009 Page 4 of 5

Notification of of Medicines 42/26/0132 SANDOZ SA (PTY) SANDOZ VINORELBINE 10 mg/1 ml 42/26/0133 SANDOZ SA (PTY) SANDOZ VINORELBINE 50 mg/5 ml Each vial contains: VINORELBINE 10,0 mg Each vial contains: VINORELBINE 42/26/0134 SANDOZ SA (PTY) NEUVEL 10 mg/1 ml Each vial contains: VINORELBINE 10,0 mg 42/26/0135 SANDOZ SA (PTY) NEUVEL 50 mg/5 ml Each vial contains: VINORELBINE 42/5.7.1/0143 PHARMACARE ASPEN CETIRIZINE 1 mg/ml 42/20.2.2/0446 GLENMARK PHARMACEUTICALS SOUTH AFRICA (PTY) GLENMARK TERBINAFINE 250 CETIRIZINE DIHYDROCHLORIDE 1,0 mg TERBINAFINE to TERBINAFINE 2 42/20.1.1/0592 BAYER (PTY) MOXIBAY IV Each 250,0 ml solution contains: to 400,0 mg 42/20.1.1/0593 BAYER (PTY) MOXIBAY TABLETS to 400,0 mg 42/20.1.1/0594 BAYER (PTY) BAYQUIN TABLETS to 400,0 mg 42/20.1.1/0595 BAYER (PTY) BAYQUIN IV Each 250,0 ml solution contains: to 400,0 mg MS MANDISA HELA REGISTRAR OF MEDICINES 12.48 Notification of Aug09v1.doc September 2009 Page 5 of 5